Skip to main content

Table 1 Patient and tumour characteristics

From: Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Characteristics No. (%)
All patients 104 (100)
Age (years; mean 56.2)  
   ≤ 50 33 (32)
   51–60 29 (28)
   >60 42 (40)
Menopause  
   Premenopausal 30 (29)
   Postmenopausal 74 (71)
Grade  
   2 71 (68)
   3 33 (32)
pTb  
   1 17 (16)
   2 86 (83)
   4 1 (1)
pNb  
   0 29 (28)
   1 75 (72)
pMb  
   0 104 (100)
Stageb  
   I 3 (3)
   IIa 40 (38)
   IIb 60 (58)
   IIIb 1 (1)
Histology  
   Ductal 103 (99)
   Scirrhous 1 (1)
Therapya  
   Tamoxifen 70 (67)
   Radiotherapy 51 (49)
   Cyclophosphamide/Methotrexate/5-Fluorouracil 28 (27)
   Cyclophosphamide/Adriamycin/5-Fluorouracil 1 (1)
   Cyclophosphamide/Adriamycin 1 (1)
   Progesterone 1 (1)
   Letrozol 1 (1)
  1. aSome patients received more than one special treatment.
  2. bAccording to [15]